Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer

Journal of Urology

Volumn 163, Issue 3, 2000, Pages 845-850

  Pisansky, Thomas M ^a   Kozelsky, Timothy F ^a   Myers, Robert P ^a   Hillman, David W ^a   Blute, Michael L ^a   Buskirk, Steven J ^a   Cheville, John C ^a   Ferrigni, Robert G ^a   Schild, Steven E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Radiotherapy

Indexed keywords

ANTIANDROGEN; DNA; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE;

EID: 0033972479     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67817-2     Document Type: Article

References (24)

1. Murphy, G. P., Mettlin, C., Menck, H. et al: National patterns of prostate cancer treatment by radical prostatectomy: results of a survey by the American College of Surgeons Committee on Cancer. J Urol, part 2, 152: 1817, 1994
2. McCarthy, J. F., Catalona, W. J. and Hudson, M. A.: Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J Urol, 151: 1575, 1994
3. Haab, F., Meulemans, A., Boccon-Gibod, L. et al: Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay. Urology, 45: 1022, 1995
4. Wu, J. J., King, S. C., Montana, G. S. et al: The efficacy of post-prostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys, 32: 317, 1995
5. Coetzee, L. J., Hars, V. and Paulson, D. F.: Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. Urology, 47: 232, 1996
6. Medini, E., Medini, I., Reddy, P. K. et al: Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up. Cancer, 78: 1254, 1996
7. Schild, S. E., Buskirk, S. J., Wong, W. W. et al: The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol, 156: 1725, 1996
8. Crane, C. H., Rich, T. A., Read, P. W. et al: Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. Int J Radiat Oncol Biol Phys, 39: 681, 1997
9. Forman, J. D., Meetze, K., Pontes, E. et al: Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol, 158: 1436, 1997
10. Morris, M. M., Dallow, K. C., Zietman, A. L. et al: Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys, 38: 731, 1997
11. Cadeddu, J. A., Partin, A. W., DeWeese, T. L. et al: Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol, 159: 173, 1998
12. Do, T., Parker, R. G., Do, C. et al: Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Cancer J Sci Am, 4: 324, 1998
13. Prostate. In.: AJCC Cancer Staging Manual, 5th ed. Edited by I. D. Fleming, J. S. Cooper, D. E. Henson et al. Philadelphia: Lippincott-Raven, p. 219, 1997
14. Utz, D. C. and Farrow, G. M.: Pathologic differentiation and prognosis of prostatic carcinoma. JAMA, 209: 1701, 1969
15. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53: 457, 1958
16. Cox, D. R.: Regression models and life tables. J Roy Stat Soc, 34: 187, 1972
17. Lightner, D. J., Lange, P. H., Reddy, P. K. et al: Prostate specific antigen and local recurrence after radical prostatectomy. J Urol, 144: 921, 1990
18. Fowler, J. E., Brooks, J., Pandey, P. et al: Variable histology of anastomotic biopsies with detectable prostate specific antigen after radical prostatectomy. J Urol, 153: 1011, 1995
19. Connolly, J. A., Shinohara, K., Presti, J. C., Jr. et al: Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology, 47: 225, 1996
20. Decision trees and management guidelines. Patterns of Care Committees. Semin Radiat Oncol, 7: 163, 1997
21. Eulau, S. M., Tate, D. J., Stamey, T. A. et al: Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. Int J Radiat Oncol Biol Phys, 41: 735, 1998
22. Ferrari, A. C., Stone, N. N., Eyler, J. N. et al: Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. J Natl Cancer Inst, 89: 1498, 1997
23. Kahn, D., Williams, R. D., Haseman, M. K. et al: Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy. J Clin Oncol, 16: 284, 1998
24. 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. J Urol, 159: 2041, 1998